SCM
MRNA icon

Step Capital Management’s Moderna MRNA Stock Holding History

Step Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-440,000
Closed -$13M – 31
2025
Q4 		$13M Buy
+440,000
New +$12M 5.94% 6

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Step Capital Management's MRNA Position: Q2 2026 in Review

Step Capital Management increased its Moderna (MRNA) stake by 7.8% in Q2 2026, buying an estimated $2.59M and bringing the position to 695,000 shares worth $48.7M. The position accounts for 10.51% of the portfolio, ranked #3.

Step Capital Management first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 614 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Step Capital Management held 695,000 shares of Moderna worth $48.7M as of Q2 2026.
  • Step Capital Management bought 50,000 Moderna shares in Q2 2026, an estimated $2.59M.
  • Moderna made up 10.51% of Step Capital Management's portfolio in Q2 2026, its #3 holding.
  • Step Capital Management first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 614 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Step Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.